Study: Retina specialists gaining awareness of biosimilars: Specialists seek more information for use in treatment of retinal diseases.

BIOTHERAPY; SAFETY; ATTITUDES of medical personnel; OPHTHALMOLOGISTS; MEDICAL technology; MEDICAL care costs; SELF-consciousness (Awareness); RETINAL diseases; INFORMATION-seeking behavior

The article discusses a survey which found that most retina specialists in the U.S. and Europe are familiar with the use of anti-VEGF biosimilars but need more information to become comfortable with their use in treating retinal disease according to Dr. Baruch Kupperman. Dr. Kupperman discussed the survey during a presentation at the American Academy of Ophthalmology 2022 Annual Meeting. Also mentioned are the primary purpose of the survey and concern on the safety of the technology.